Day, Date, and Time: Saturday, 18th April 2026, 9:30 am to 10:15 am
In an era of rapid technological disruption and climate consciousness, the survival of healthcare enterprises depends on their ability to build robust innovation pipelines while maintaining sustainable business models. An innovation pipeline is not merely a collection of new ideas but a structured strategic flow from R&D to market entry that ensures a steady delivery of value-based solutions. This session examines how industry leaders balance the high costs of medical "moonshots" with the economic necessity of long-term environmental, social, and financial sustainability.
The focus shifts from short-term profitability to "Triple Bottom Line" success: People, Planet, and Profit. For the Indian healthcare sector, this involves navigating high-volume, low-margin markets like those under Ayushman Bharat by leveraging frugal innovation and digital scale. By integrating circular economy principles into supply chains and utilizing data-driven insights to predict market needs, organizations can de-risk their innovation journeys and ensure they remain resilient against global economic shifts.
Strategic Benefits
Session Focus
This session provides a deep dive into the practicalities of managing the "Innovation-Sustainability" paradox. It will explore frameworks for building agile R&D pipelines that can pivot in response to real-world data and emerging health threats. Speaker will share industry insights on transitioning from traditional fee-for-service models to sustainable, value-based care models that incentivize long-term wellness. Session will also cover the role of public-private partnerships (PPP) in scaling innovations for underserved populations, particularly in the context of the Indian digital health mission.
Key Takeaways
Citizen Centric Smart Healthcare shifts the focus of health systems from episodic treatment to a holistic, care-centric model where the citizen rather than the disease or insurance package is at the center. By leveraging cutting-edge technologies like Artificial Intelligence (AI), Internet of Medical Things (IoMT), and digital platforms, this approach empowers individuals to take ownership of their health journeys. In the Indian context, initiatives like the Ayushman Bharat Digital Mission (ABDM) are foundational, creating a unified ecosystem where secure, consent-based access to digital health records ensures transparency and continuity of care across public and private sectors.
Smart healthcare utilizes AI-driven tools, wearable devices, and mobile health (mHealth) services to move from passive care to active participation. Citizens can now monitor vital signs continuously, allowing for early risk identification and proactive interventions. For diverse and large populations, this framework enables "personalization at scale," where AI analyzes health data to identify regional trends and tailor public health strategies to local needs while respecting privacy and ethics.
Strategic Benefits
Session Focus
This session explores the transition from traditional, fragmented healthcare to an integrated, citizen-first ecosystem. It examines the role of enabling technologies like blockchain for secure data sharing and AI for predictive analytics in clinical settings. Discussions will highlight real-world implementations, such as the use of unique health IDs (ABHA) in India, and address critical challenges including the digital divide, data privacy, and the need for robust infrastructure.
Key Takeaways
Smart Healthcare represents the seamless integration of advanced technologies such as the Internet of Medical Things (IoMT), Artificial Intelligence (AI), and Big Data into clinical workflows to create a proactive and personalized care model. In this digital era, accreditation serves as the essential bridge between technological innovation and standardized patient safety. By aligning digital transformation with rigorous frameworks like NABH and JCI, healthcare organizations can ensure that "smart" interventions lead to measurable improvements in clinical outcomes and operational efficiency.
In the context of India’s rapidly evolving digital health ecosystem, including the Ayushman Bharat Digital Mission (ABDM), accreditation provides the necessary guardrails for data security, interoperability, and ethical AI use. As hospitals move toward paperless environments and remote monitoring, the focus of quality assurance shifts from manual audits to real-time, data-driven compliance. This evolution ensures that technology serves as a catalyst for safety rather than a source of new risks, such as algorithmic bias or data breaches.
Strategic Benefits
Session Focus
This session explores the intersection of digital health maturity and international accreditation standards. It will examine practical frameworks for implementing "Smart Hospital" features such as AI-driven diagnostics and ambient clinical intelligence while maintaining strict adherence to safety protocols. Experts will discuss the transition from traditional quality management to "Quality 4.0," highlighting case studies of successful digital accreditation journeys in both large corporate hospitals and public health setups.
Key Takeaways
The healthcare sector plays a vital role in safeguarding human health; however, it is also a significant contributor to environmental pollution, carbon emissions, and resource depletion. Hospitals consume large volumes of energy and water, generate biomedical and hazardous waste, and rely on complex supply chains that impact the environment. In the context of climate change and sustainable development, integrating eco-friendly practices into hospital operations has become a global priority.
This conference session at the SYMHEALTH 2026 Conference aims to explore eco- friendly practices and green certification frameworks adopted by hospitals worldwide to promote environmental sustainability without compromising the quality of care. The session will highlight key sustainability interventions such as energy-efficient infrastructure, renewable energy use, water conservation, green building design, waste segregation and recycling, sustainable procurement, and environmentally responsible clinical practices.
Key Takeaways
Healthcare facilities operate continuously and are among the most resource-intensive institutions, requiring substantial energy, water, and efficient biomedical waste management systems. With the growing demand for healthcare services, hospitals must adopt sustainable operational practices that minimize environmental impact while maintaining quality patient care. Predictive sustainability uses data analytics, digital monitoring, and intelligent technologies to anticipate resource needs, optimize energy consumption, and improve waste management practices in healthcare facilities.
This session will highlight how technologies such as artificial intelligence, IoT-enabled monitoring systems, and predictive analytics can support hospitals in reducing energy consumption, improving operational efficiency, and managing biomedical waste responsibly. It will also discuss global sustainability trends and practical strategies for healthcare administrators to implement environmentally responsible systems within hospital infrastructure. Predictive energy management systems can optimize power consumption in critical areas such as operating theatres, diagnostic units, and HVAC systems, thereby reducing operational costs and carbon emissions. Similarly, intelligent waste management systems help hospitals track biomedical waste generation, segregate waste efficiently, and ensure compliance with environmental and regulatory standards. The session will highlight global trends, innovative practices, and practical strategies that healthcare administrators can adopt to build environmentally responsible healthcare organizations.
Key Takeaways
With the rapid expansion of pharmaceutical innovation and global clinical research, ensuring drug safety has become a critical component of modern healthcare systems. Pharmacovigilance—the science of detecting, assessing, understanding, and preventing adverse effects of medicines—plays a central role in safeguarding patient health throughout the lifecycle of a drug. As
healthcare systems become increasingly data-driven and interconnected, traditional pharmacovigilance practices are evolving to incorporate advanced technologies, global collaboration, and real-time safety monitoring.
Transforming drug safety requires integrating advanced analytics, digital health technologies, and regulatory science into pharmacovigilance frameworks. The use of big data, artificial intelligence, and global safety databases enable healthcare organizations and pharmaceutical companies to detect safety signals earlier, evaluate risk more effectively, and respond promptly to emerging safety concerns. These advancements improve patient outcomes while strengthening public trust in medicines and healthcare systems.
At the same time, the transformation of pharmacovigilance requires strong leadership, robust governance structures, and collaboration between regulators, pharmaceutical companies, healthcare professionals, and technology innovators. Effective pharmacovigilance systems must ensure transparency, timely reporting of adverse events, continuous monitoring of drug safety, and proactive risk management strategies throughout clinical development and post- marketing surveillance.
The speaker for this session is Dr. Deepa Arora, an experienced clinical development and drug safety physician who currently serves as the Chief Executive Officer of Clinexel . With extensive leadership experience in pharmacovigilance and clinical development, she has played a significant role in advancing global drug safety strategies and strengthening regulatory compliance across the pharmaceutical industry. Prior to her current role, she served as Vice President and Global Head of Drug Safety & Risk Management at Lupin Limited , where she led global pharmacovigilance initiatives and strategic safety programs.
Dr. Arora also contributes to the global life sciences ecosystem through advisory and board roles, including serving as Director at Ajna Therapeutics and Board Member at The Econophy Group LLC , providing strategic guidance on clinical development, innovation, and regulatory strategy.
In this session, Dr. Arora will share insights on how modern pharmacovigilance systems are evolving to meet the challenges of global drug development , including the role of technology in safety monitoring, integration of real-world data, and strategies for improving risk management throughout the drug lifecycle. The discussion will highlight how leadership, innovation, and cross-sector collaboration can transform drug safety practices and strengthen patient protection in an increasingly complex pharmaceutical landscape.
For students and professionals attending SYMHEALTH 2026, this session will offer valuable perspectives on the future of pharmacovigilance, regulatory science, and drug safety management , and how these disciplines are shaping safer and more effective healthcare systems worldwide.
Key Takeaways
The development of safe and effective medicines depends heavily on the efficiency and reliability of clinical trials. However, traditional clinical trial processes are often time‑consuming, expensive, and complex, involving multiple stakeholders, large datasets, and strict regulatory requirements. In recent years, technological advancements have begun to transform the way clinical trials are designed, conducted, and monitored, creating opportunities to significantly improve efficiency and accuracy.
Digital technologies such as artificial intelligence, big data analytics, cloud computing, and electronic data capture systems are increasingly being integrated into clinical research processes. These innovations enable researchers to collect and analyze large volumes of clinical data in real time, improve patient recruitment and monitoring, and reduce operational delays. By streamlining data management and enhancing collaboration between research teams, these technologies help accelerate the clinical trial lifecycle while maintaining high standards of safety and regulatory compliance.
Technology‑enabled clinical trials also support more patient‑centric approaches. Tools such as remote monitoring, wearable devices, telemedicine platforms, and decentralized clinical trial models allow researchers to collect real‑world data while reducing the burden on participants. This not only improves patient engagement but also increases the diversity and quality of clinical trial data, ultimately leading to more reliable research outcomes.
The speaker for this session, Dr. Chitra Lele, Managing Director for Life Sciences Consulting at NTT DATA, brings extensive experience in leveraging technology to improve healthcare and life sciences operations. Through her work in digital transformation and healthcare consulting, she has contributed to the development of innovative technology solutions that enhance research efficiency and support data‑driven decision making within the life sciences industry.
TIn this session, Dr. Lele will discuss how emerging technologies are acting as catalysts in improving clinical trial efficiency. The session will highlight how digital transformation is reshaping clinical research by improving data quality, reducing timelines, and enabling better collaboration among researchers, pharmaceutical companies, and regulatory bodies. It will also explore how advanced technologies can help overcome traditional challenges in clinical trials and accelerate the development of new therapies.
For students attending the SymHealth 2026, particularly those from healthcare management, life sciences, and pharmaceutical backgrounds, this session will provide valuable insights into how technology is transforming clinical research processes. It will help participants understand the importance of integrating digital tools into clinical trial management and how these innovations contribute to faster and more efficient drug development.
Key Takeaways
This concept note outlines a conference session on integrating operational efficiency with compassionate care in healthcare leadership. It targets management educators and professionals seeking practical frameworks for resilient, patient-centered organizations.
Session Overview
Healthcare leadership requires mastering the dual imperatives of streamlined operations and empathetic engagement, especially amid resource constraints and rising demands. This session explores how leaders can optimize processes like resource allocation and digital workflows while fostering trust, reducing burnout, and enhancing patient outcomes. Transformational approaches blend data-driven decisions with emotional intelligence to create cultures where efficiency amplifies compassion rather than eroding it.
Objectives
Key Discussion Points
Target Audience
The students pursuing various degree/diploma programs in healthcare management, faculty, industry leaders from Symbiosis International University affiliates, researchers, and policymakers (150-200 participants).
Format and Duration
45 minutes: 30-minute presentation, 15 minute interactive Q&A.
Expected Outcomes
Attendees will depart with actionable frameworks, leadership toolkits, and networks to implement balanced strategies, fostering compassionate efficiency in their institutions.
Rationale
This topic addresses a critical leadership gap, aligning with global shifts toward value-based care where compassionate efficiency drives better patient engagement, reduced errors, and organizational resilience—essential for India's evolving $372 billion healthcare market.
This concept note outlines a session exploring healthcare's evolution from infrastructure- heavy models to intelligent, technology-driven systems. It emphasizes predictive analytics, precision medicine, and personalized care as core to this shift.
Session Overview
Traditional healthcare relies on hospitals, beds, and physical facilities, but the new paradigm prioritizes digital ecosystems like AI diagnostics, remote monitoring, and data interoperability. This transition enables proactive interventions, reducing reliance on inpatient care while improving outcomes through wearable tech and virtual platforms. In India, initiatives like Ayushman Bharat Digital Mission accelerate this by fostering seamless data sharing and scalable access.
Objectives
Key Discussion Points
Target Audience
The students pursuing various degree/diploma programs in healthcare management, faculty, industry leaders from Symbiosis International University affiliates, researchers, and policymakers (150-200 participants).
Format and Duration
45 minutes: 30-minute presentation, 15 minute interactive Q&A.
Expected Outcomes
Participants will acquire frameworks to design infrastructure-light healthcare strategies, initiate industry-academia partnerships, and influence policy for India's digital health growth.
Rationale
This topic redefines healthcare beyond capital-intensive builds, aligning with global trends toward value-based, patient-centric systems projected to dominate by 2026. It equips management professionals with tools for resilient, tech-forward operations.
Session Overview
India’s vulnerable populations—including pregnant and lactating women, infants and young children, adolescents, the elderly, and socio-economically disadvantaged communities—face a disproportionate burden of malnutrition, micronutrient deficiencies, and rising non-communicable diseases. Conventional “one-size-fits-all” nutrition interventions often fail to account for individual variability, local dietary practices, and contextual risk factors.
Advances in precision nutrition, digital health tools, and data-driven risk stratification are enabling the design of personalized, context-specific nutrition strategies that can better address the needs of vulnerable groups. This session will explore how individualized nutrition approaches, supported by technology and community-based systems, can improve nutrition outcomes, health equity, and programme effectiveness in India.
Objectives
Key Discussion Points
Target Audience
Format and Duration
Expected Outcomes
Rationale
India’s nutrition challenges are deeply rooted in diversity, inequality, and complex socio-cultural dynamics, making generalized interventions less effective in reaching those most at risk. Vulnerable populations often require tailored nutrition solutions that consider life-stage needs, local food systems, health status, and access to services.
Personalized nutrition offers a transformative pathway to improve targeting, enhance adherence, and optimize outcomes, especially when combined with digital tools and community-based delivery systems. By aligning precision approaches with public health frameworks, India can move toward more responsive, efficient, and inclusive nutrition programmes.
This session is timely in highlighting how personalized nutrition can bridge gaps in equity and effectiveness, contributing to the broader goals of Suposhit Bharat and future-ready healthcare systems.
Session Overview
Advancements in food processing are rapidly transitioning from conventional preservation and mass production approaches to smart, data-driven, and precision-oriented systems. Emerging technologies such as AI-enabled processing, sensor-based quality control, nutrigenomics-informed formulation, and minimally invasive processing techniques are enabling the development of foods tailored to specific metabolic, clinical, and population needs.
This session will explore how next-generation food processing technologies can enhance nutrient retention, bioavailability, and functional efficacy, while aligning with the goals of precision nutrition and preventive healthcare in India.
Objectives
Key Discussion Points
Target Audience
Format and Duration
Expected Outcomes
Rationale
IIndia is facing a complex nutrition landscape, marked by the coexistence of undernutrition, micronutrient deficiencies, and rising non-communicable diseases. Traditional food processing approaches often compromise nutrient quality or fail to address individual variability in metabolic responses.
With the emergence of smart food processing technologies, there is an opportunity to transform food systems into nutrition-sensitive, data-driven platforms that deliver targeted health benefits. This is particularly relevant in the context of precision public health and the vision of a Suposhit Bharat, where food is not just sustenance but a strategic tool for disease prevention and health optimization.
This session aims to bridge the gap between food technology, nutrition science, and digital innovation, enabling stakeholders to envision future-ready food systems aligned with India’s healthcare transformation goals.
Session Overview
India is witnessing rapid growth in the nutraceuticals and functional foods sector, driven by increasing consumer awareness, rising burden of lifestyle diseases, and a shift toward preventive healthcare. Rooted in traditional knowledge systems and supported by modern science, Indian nutraceuticals are uniquely positioned to address both nutritional deficiencies and metabolic health challenges.
This session will examine the evolving landscape of science-backed nutraceuticals, bioactive-rich functional foods, and personalized nutrition products, alongside innovations in formulation, validation, and delivery systems. It will also explore how India can emerge as a global leader in evidence-based, affordable nutraceutical solutions.
Objectives
Key Discussion Points
Target Audience
Format and Duration
Expected Outcomes
Rationale
India stands at a critical intersection where traditional dietary wisdom meets modern biomedical science. With the growing burden of diabetes, cardiovascular diseases, and micronutrient deficiencies, there is an urgent need for accessible, preventive, and culturally relevant nutrition solutions.
Nutraceuticals and functional foods offer a promising pathway to address these challenges by delivering targeted health benefits beyond basic nutrition. However, their long-term success depends on robust scientific validation, regulatory clarity, and consumer trust.
This session is timely, as it aims to position India not just as a consumer market but as a global innovator in evidence-based nutraceuticals, aligned with the vision of precision, personalized, and preventive healthcare systems.
Session Overview
India is undergoing a rapid digital transformation, creating unprecedented opportunities to reimagine healthcare delivery, nutrition surveillance, and disease prevention. From mobile health platforms and wearable technologies to artificial intelligence, big data analytics, and digital public health systems, technology is enabling a shift from reactive care to predictive, preventive, and personalized health systems.
In the context of India’s dual burden of malnutrition and rising non-communicable diseases, digital innovations can enhance dietary assessment, real-time monitoring, risk prediction, and behaviour change interventions at scale. This session will explore how Digital India initiatives and emerging technologies are transforming nutrition and health outcomes, particularly in diverse and resource-constrained settings.
Objectives
Key Discussion Points
Target Audience
Format and Duration
Expected Outcomes
Rationale
Achieving a Healthy India requires leveraging the full potential of the Digital India movement to address persistent and emerging health challenges. Conventional approaches to nutrition and disease prevention are often limited by data gaps, delayed insights, and fragmented service delivery.
Digital technologies offer the ability to capture real-time data, generate predictive insights, and deliver personalized interventions, thereby improving both efficiency and impact. However, translating these innovations into meaningful health outcomes requires careful attention to equity, accessibility, and system integration.
This session is timely in highlighting how India can harness digital transformation to build future-ready, resilient, and inclusive health systems, advancing the vision of Suposhit Bharat and preventive healthcare for all.
Session Overview
Childhood growth faltering—including stunting, wasting, and underweight—remains a significant public health challenge in India, with long-term consequences on cognitive development, immunity, educational outcomes, and economic productivity. Despite multiple national programmes, gaps persist in early identification, targeting, and timely intervention, particularly during the first 1,000 days of life.
The emergence of digital health platforms, real-time data systems, and predictive analytics offers an opportunity to shift from generalized approaches to data-guided, targeted nutrition strategies. By leveraging growth monitoring data, maternal health indicators, dietary patterns, and socio-demographic insights, stakeholders can identify at-risk children early and deliver precision interventions at the right time.
This session will explore how data-driven approaches can strengthen prevention of growth faltering and improve child nutrition outcomes across diverse Indian settings.
Objectives
Key Discussion Points
Target Audience
Format and Duration
Expected Outcomes
Rationale
India has made progress in improving child nutrition; however, growth faltering remains a persistent issue due to delayed detection, fragmented data systems, and limited targeting of interventions. Addressing this challenge requires a shift from reactive programme delivery to proactive, data-driven strategies.
Data-guided nutrition approaches enable early identification of vulnerable children, efficient allocation of resources, and timely, context-specific interventions, particularly during critical growth periods. When integrated with community-based delivery systems and national programmes, these approaches can significantly enhance the impact of nutrition interventions.
This session is timely in highlighting how data and digital innovations can transform child nutrition programmes, contributing to improved growth outcomes and supporting India’s vision of a healthier, well-nourished future generation.
Session Overview
India’s rich heritage of medicinal plants offers a vast repository of bioactive compounds with demonstrated potential to modulate gut microbiota, immune function, and metabolic health. With growing scientific validation, traditional herbs such as turmeric, ashwagandha, tulsi, and giloy are increasingly being explored through the lens of precision nutrition and personalized healthcare.
This session will examine how Indian herbal bioactives can be integrated into modern nutrition strategies to deliver targeted gut and immune health benefits, supported by advances in phytochemistry, nutrigenomics, microbiome science, and AI-driven personalization. The focus will be on bridging traditional knowledge systems with evidence-based, individualized nutrition interventions.
Objectives
Key Discussion Points
Target Audience
Format and Duration
Expected Outcomes
Rationale
India faces a rising burden of immune-related disorders, gastrointestinal diseases, and metabolic conditions, alongside persistent challenges of undernutrition. At the same time, there is renewed global interest in plant-based bioactives and traditional medicine systems.
Indian herbs offer a unique opportunity to develop culturally relevant, accessible, and preventive health solutions, particularly when integrated with modern tools such as microbiome profiling and personalized nutrition algorithms. However, to fully realize this potential, there is a need to move beyond anecdotal use toward scientifically validated, standardized, and precision-guided applications.
This session is timely in positioning Indian herbal bioactives as a cornerstone of future-ready, personalized gut and immune health strategies, contributing to the broader vision of Suposhit Bharat and smart healthcare systems.
Session Overview
The human gut microbiome has emerged as a critical determinant of metabolic health, immunity, and disease risk, influencing individual responses to diet and nutrients. However, most microbiome research has been dominated by Western populations, limiting its applicability to diverse Indian contexts characterized by unique dietary patterns, genetic diversity, environmental exposures, and cultural practices.
This session will focus on the importance of identifying and leveraging Indian microbiome signatures to design context-specific, personalized nutrition strategies. It will explore advances in microbiome profiling, AI-driven analytics, and diet–microbiome interactions, with an emphasis on translating research into clinically and public health-relevant applications in India.
Objectives
Key Discussion Points
Target Audience
Format and Duration
Expected Outcomes
Rationale
India’s vast diversity in dietary habits, geography, and socio-cultural practices creates distinct microbiome profiles that are not adequately captured in global datasets. Applying generalized microbiome-based recommendations without local validation risks ineffective or suboptimal nutrition interventions.
Integrating Indian microbiome signatures into personalized nutrition offers a powerful opportunity to enhance dietary precision, improve metabolic outcomes, and support preventive healthcare strategies. This is particularly relevant in addressing the dual burden of undernutrition and rising non-communicable diseases.
This session aligns strongly with the vision of smart healthcare systems, where data-driven, individualized, and culturally relevant nutrition strategies can significantly improve health outcomes at both individual and population levels.
Session Overview
India is home to one of the largest populations living with diabetes, with dietary patterns playing a central role in disease onset and management. However, conventional approaches such as glycemic index (GI) and standardized dietary guidelines often fail to capture the significant inter-individual variability in glycemic responses, particularly within diverse Indian populations.
Recent advances in continuous glucose monitoring (CGM), metabolomics, microbiome research, and AI-driven analytics have enabled the mapping of personalized glycemic responses to specific foods and meals. This session will explore how glycemic response mapping of Indian foods—including staples, traditional recipes, and emerging functional foods—can inform precision nutrition strategies for diabetes prevention and management.
Objectives
Key Discussion Points
Target Audience
Format and Duration
Expected Outcomes
Rationale
India’s diabetes epidemic necessitates a shift from generic dietary guidelines to personalized nutrition approaches that account for individual metabolic responses and cultural dietary diversity. Traditional metrics such as GI, while useful, are insufficient to guide real-world dietary decision-making in complex meal patterns typical of Indian diets.
Glycemic response mapping represents a paradigm shift in diabetes care, enabling the design of data-driven, individualized nutrition strategies that can improve glycemic control and reduce long-term complications.
This session is highly relevant in advancing the goals of precision health systems, where technology-enabled insights can empower both clinicians and individuals to make more informed, context-specific dietary choices, contributing to better diabetes outcomes in India.
Session Overview
India is at a critical inflection point, facing a rapidly escalating burden of non-communicable diseases (NCDs) including diabetes, cardiovascular diseases, and obesity—often emerging earlier and progressing more aggressively than in many global populations. Traditional public health approaches, which rely on retrospective data and broad interventions, are increasingly inadequate to address this evolving challenge.
Advances in predictive analytics, artificial intelligence, epidemiological modelling, and systems biology now offer the ability to forecast disease trajectories, identify high-risk populations, and design targeted, preventive interventions. This session will explore how predictive models integrating nutrition, lifestyle, genetic, and environmental data can inform strategies to reduce India’s NCD burden by 2047.
Objectives
Key Discussion Points
Target Audience
Format and Duration
Expected Outcomes
Rationale
India’s demographic and epidemiological transition demands a shift from reactive healthcare to predictive and preventive systems. The rising burden of NCDs not only impacts population health but also poses significant economic and healthcare system challenges.
Predictive modelling offers a transformative approach by enabling early identification of at-risk individuals and populations, optimizing resource allocation, and guiding evidence-based policy decisions. When combined with insights from nutrition science and metabolic health, these models can support the design of high-impact, targeted interventions.
This session is timely in framing a forward-looking vision for India’s metabolic health, where data-driven foresight and precision strategies can significantly reduce disease burden and contribute to building a healthier, more resilient nation by 2047.
Session Overview
India’s nutrition landscape is characterized by a dual burden of malnutrition, where undernutrition, micronutrient deficiencies, and rising non-communicable diseases coexist. Traditional methods of dietary assessment and nutrition surveillance are often time- intensive, retrospective, and limited in scalability.
With the emergence of artificial intelligence, digital health platforms, and real-time data systems, there is a transformative opportunity to reimagine how dietary intake, nutrient adequacy, and behavioural patterns are assessed and acted upon.
This panel will bring together experts from nutrition science, public health, data science, and policy to discuss how AI-enabled tools can enhance dietary assessment accuracy, enable dynamic nutrient profiling, and generate actionable behaviour insights for diverse Indian populations—thereby advancing the goal of a Suposhit Bharat.
Objectives
Key Discussion Points
Target Audience
Format and Duration
Expected Outcomes
Rationale
Achieving the vision of a Suposhit Bharat requires moving beyond static and generalized approaches toward real-time, data-driven, and individualized nutrition strategies. AI- enabled dietary assessment and nutrient profiling systems offer the potential to bridge gaps in data accuracy, timeliness, and scalability, especially in a diverse country like India.
Moreover, understanding behavioural drivers of food choices is critical to ensuring that nutrition interventions are not only evidence-based but also culturally relevant and sustainable.
Moreover, understanding behavioural drivers of food choices is critical to ensuring that nutrition interventions are not only evidence-based but also culturally relevant and sustainable.
Session Overview
India’s vulnerable populations—including pregnant and lactating women, infants and young children, adolescents, the elderly, and socio-economically disadvantaged communities—face a disproportionate burden of malnutrition, micronutrient deficiencies, and rising non-communicable diseases. Conventional “one-size-fits-all” nutrition interventions often fail to account for individual variability, local dietary practices, and contextual risk factors.
Advances in precision nutrition, digital health tools, and data-driven risk stratification are enabling the design of personalized, context-specific nutrition strategies that can better address the needs of vulnerable groups. This session will explore how individualized nutrition approaches, supported by technology and community-based systems, can improve nutrition outcomes, health equity, and programme effectiveness in India.
Objectives
Key Discussion Points
Target Audience
Format and Duration
Expected Outcomes
Rationale
India’s nutrition challenges are deeply rooted in diversity, inequality, and complex socio-cultural dynamics, making generalized interventions less effective in reaching those most at risk. Vulnerable populations often require tailored nutrition solutions that consider life-stage needs, local food systems, health status, and access to services.
Personalized nutrition offers a transformative pathway to improve targeting, enhance adherence, and optimize outcomes, especially when combined with digital tools and community-based delivery systems. By aligning precision approaches with public health frameworks, India can move toward more responsive, efficient, and inclusive nutrition programmes.
This session is timely in highlighting how personalized nutrition can bridge gaps in equity and effectiveness, contributing to the broader goals of Suposhit Bharat and future-ready healthcare systems.
Session Overview
Micronutrient deficiencies—often termed “hidden hunger”—remain a major public health challenge in India, disproportionately affecting women, children, and vulnerable populations. Anaemia alone continues to have high prevalence, impacting maternal health, child development, productivity, and intergenerational outcomes.
Conventional approaches to detection rely on periodic surveys and clinical screening, which are often delayed and limited in coverage. Emerging advances in predictive analytics, artificial intelligence, and integrated data systems offer the potential to identify individuals and populations at risk before clinical manifestation, enabling timely and targeted interventions.
This session will explore how data-driven predictive models, leveraging inputs from dietary intake, socio-demographic factors, health records, and programmatic data, can strengthen early detection and prevention of micronutrient deficiencies in India.
Objectives
Key Discussion Points
Target Audience
Format and Duration
Expected Outcomes
Rationale
Despite decades of interventions, micronutrient deficiencies persist due to delayed detection, limited personalization, and gaps in programme targeting. Addressing hidden hunger requires moving from reactive supplementation approaches to proactive, predictive systems.
Predictive analytics enables early risk identification, efficient resource allocation, and tailored interventions, particularly crucial in a diverse country like India with varying dietary patterns and socio-economic conditions.
This session is timely in demonstrating how data-driven insights can transform nutrition programmes, enabling India to tackle hidden hunger more effectively and move closer to the vision of a Suposhit, healthy, and productive population.
Session Overview
Food adulteration remains a persistent public health concern in India, affecting food safety, nutritional quality, and consumer trust. Conventional surveillance mechanisms are often reactive, fragmented, and resource-intensive, limiting their ability to detect and prevent adulteration in real time.
With the advancement of artificial intelligence, machine learning, IoT-enabled sensors, blockchain traceability, and big data analytics, there is a growing opportunity to shift toward predictive surveillance systems. These systems can identify high-risk commodities, supply chain vulnerabilities, and temporal patterns of adulteration, enabling timely and targeted interventions.
This session will explore how technology-driven predictive surveillance frameworks can strengthen food safety systems, enhance regulatory efficiency, and safeguard public health in India.
Objectives
Key Discussion Points
Target Audience
Format and Duration
Expected Outcomes
Rationale
Ensuring food safety is fundamental to achieving nutrition security and public health goals in India. Food adulteration not only compromises nutrient integrity but also poses serious health risks, particularly among vulnerable populations.
Traditional inspection-based systems are insufficient to manage the scale and complexity of India’s food supply chains. Predictive surveillance systems offer a paradigm shift by enabling risk-based, data-driven, and anticipatory action, rather than reactive enforcement.
This session is timely in highlighting how India can leverage digital innovation and predictive intelligence to build safer, transparent, and accountable food systems, contributing to the broader vision of Suposhit Bharat and smart healthcare ecosystems.
